Drew Cutler

497 total citations
21 papers, 377 citations indexed

About

Drew Cutler is a scholar working on Surgery, Transplantation and Epidemiology. According to data from OpenAlex, Drew Cutler has authored 21 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Transplantation and 5 papers in Epidemiology. Recurrent topics in Drew Cutler's work include Renal Transplantation Outcomes and Treatments (11 papers), Transplantation: Methods and Outcomes (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Drew Cutler is often cited by papers focused on Renal Transplantation Outcomes and Treatments (11 papers), Transplantation: Methods and Outcomes (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Drew Cutler collaborates with scholars based in United States. Drew Cutler's co-authors include Richard Chinnock, Stephen Ashwal, Shobha Sahney, Craig W. Zuppan, Francis J. DiMario, Elizabeth A. Thiele, Sandra L. Dabora, David Neal Franz, Susana Camposano and Darcy A. Krueger and has published in prestigious journals such as PLoS ONE, Transplantation and The Journal of Heart and Lung Transplantation.

In The Last Decade

Drew Cutler

21 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Drew Cutler United States 11 149 115 107 93 87 21 377
Antonella Fossi Italy 13 139 0.9× 137 1.2× 63 0.6× 37 0.4× 317 3.6× 34 506
Hosenpud Jd United States 11 116 0.8× 299 2.6× 41 0.4× 90 1.0× 143 1.6× 20 572
Aida Venado United States 10 50 0.3× 152 1.3× 38 0.4× 63 0.7× 147 1.7× 37 401
Maria Cristina Maresca Italy 9 14 0.1× 147 1.3× 170 1.6× 105 1.1× 54 0.6× 17 381
Kenneth L. Pinsker United States 13 68 0.5× 267 2.3× 36 0.3× 53 0.6× 189 2.2× 29 434
Deborah Sesok‐Pizzini United States 9 28 0.2× 109 0.9× 24 0.2× 107 1.2× 32 0.4× 21 474
D Mancini United States 4 24 0.2× 348 3.0× 40 0.4× 305 3.3× 23 0.3× 6 487
Leonardo Caroti Italy 11 18 0.1× 35 0.3× 59 0.6× 68 0.7× 49 0.6× 30 320
Massimo Abelli Italy 10 11 0.1× 134 1.2× 31 0.3× 59 0.6× 44 0.5× 28 271
Jorge Gutierrez United States 5 36 0.2× 299 2.6× 53 0.5× 24 0.3× 37 0.4× 6 333

Countries citing papers authored by Drew Cutler

Since Specialization
Citations

This map shows the geographic impact of Drew Cutler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew Cutler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew Cutler more than expected).

Fields of papers citing papers by Drew Cutler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drew Cutler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew Cutler. The network helps show where Drew Cutler may publish in the future.

Co-authorship network of co-authors of Drew Cutler

This figure shows the co-authorship network connecting the top 25 collaborators of Drew Cutler. A scholar is included among the top collaborators of Drew Cutler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Drew Cutler. Drew Cutler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanchez, Cheryl P., et al.. (2016). Inpatient citrate-based hemodialysis in pediatric patients. Pediatric Nephrology. 31(10). 1667–1672. 3 indexed citations
2.
Malinowska, Izabela A., Nancy Y. Lee, Elizabeth A. Thiele, et al.. (2013). Similar Trends in Serum VEGF-D Levels and Kidney Angiomyolipoma Responses with Longer Duration Sirolimus Treatment in Adults with Tuberous Sclerosis. PLoS ONE. 8(2). e56199–e56199. 14 indexed citations
3.
Baron, Pedro, Jaysson T. Brooks, D. Duane Baldwin, et al.. (2013). Comparison of outcomes of hand‐assisted laparoscopic to open donor nephrectomy for pediatric recipients. Pediatric Transplantation. 17(4). 374–379. 1 indexed citations
4.
Sahney, Shobha, et al.. (2012). 594 A New Glomerular Filtration Rate Estimation Formula Derived from a Pediatric Heart Transplant Population. The Journal of Heart and Lung Transplantation. 31(4). S205–S206. 1 indexed citations
5.
Deming, Douglas, et al.. (2011). Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients. Pediatric Transplantation. 15(7). 746–749. 22 indexed citations
6.
Dabora, Sandra L., David Neal Franz, Stephen Ashwal, et al.. (2011). Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease. PLoS ONE. 6(9). e23379–e23379. 159 indexed citations
7.
Chinnock, Richard, et al.. (2009). 535: Post-Transplant Lymphoproliferative Disease: 20 Year Experience in Infant Heart Transplant Recipients. The Journal of Heart and Lung Transplantation. 28(2). S252–S252. 1 indexed citations
8.
Sahney, Shobha, Peter D. Yorgin, Craig W. Zuppan, et al.. (2009). BK virus nephropathy in the native kidneys of a pediatric heart transplant recipient. Pediatric Transplantation. 14(3). E11–E15. 26 indexed citations
9.
Chinnock, Richard, et al.. (2008). Developmental Outcomes After Pediatric Heart Transplantation. The Journal of Heart and Lung Transplantation. 27(10). 1079–1084. 33 indexed citations
10.
Baron, Pedro, Okechukwu Ojogho, Peter D. Yorgin, et al.. (2007). Comparison of outcomes with low‐dose anti‐thymocyte globulin, basiliximab or no induction therapy in pediatric kidney transplant recipients: A retrospective study. Pediatric Transplantation. 12(1). 32–39. 18 indexed citations
11.
Ojogho, Okechukwu, Shobha Sahney, Drew Cutler, et al.. (2005). Mycophenolate mofetil in pediatric renal transplantation: Non‐induction vs. induction with basiliximab. Pediatric Transplantation. 9(1). 80–83. 15 indexed citations
12.
Baron, P., Okechukwu Ojogho, Shobha Sahney, et al.. (2003). Use of basiliximab with mycophenolate mofetil in kidney transplantation. Transplantation Proceedings. 35(8). 2881–2884. 2 indexed citations
13.
Ojogho, Okechukwu, et al.. (2003). Mycophenolate mofetil without antibody induction in cadaver vs. living donor pediatric renal transplantation. Pediatric Transplantation. 7(2). 137–141. 3 indexed citations
14.
Ojogho, Okechukwu, et al.. (2002). Mycophenolate mofetil without antibody induction in pediatric renal transplantation. Transplantation Proceedings. 34(5). 1953–1954. 2 indexed citations
15.
Ojogho, Okechukwu, et al.. (2002). Superior Long-Term Results of Renal Transplantation in Children under 5 Years of Age. The American Surgeon. 68(12). 1115–1119. 14 indexed citations
16.
Chinnock, Richard, Drew Cutler, & Marti Baum. (2000). Clinical outcome 10 years after infant heart transplantation. Progress in Pediatric Cardiology. 11(2). 165–169. 11 indexed citations
17.
Ojogho, Okechukwu, Shobha Sahney, Drew Cutler, et al.. (1999). MYCOPHENOLATE MOFETIL (MMF) IN PEDIATRIC RENAL TRANSPLANTATION. Transplantation. 67(9). S642–S642. 2 indexed citations
18.
Baum, Michel, Drew Cutler, F. Jay Fricker, Franklin Trimm, & Jess C. Mace. (1991). Session VII: Physiologic and psychological growth and development in pediatric heart transplant recipients.. PubMed. 10(5 Pt 2). 848–55. 27 indexed citations
19.
Cutler, Drew, et al.. (1974). Necrotic amebic colitis.. PubMed. 62(4). 345–9. 10 indexed citations
20.
Cutler, Drew, et al.. (1967). Acute amebic colitis with perforation.. PubMed. 18(3). 211–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026